|
Go to Agenda:
Day 1 | Day 2
DISCLOSURE SUMMIT AGENDA: DAY III
Friday, February 7, 2014
|
|
7:00 am |
Registration Commences
|
CLOSING PLENARY SESSION: CREATING A GLOBAL TRANSPARENCY COMPLIANCE PROGRAM FOR THE FUTURE
|
8:00 am
 |
Welcome and Introductions
Ashish Kalgaonkar, MBA
Senior Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN (Co-chair)
|
 |
|
8:15 am |
Global Challenge: Conducting Background Checks on the HCPs/HCOs
- Transparency reporting is requiring companies to conduct background checks on the hcps/hcos (third parties) they are doing business with.
- Third parties have different risk profiles, and depending on the risk profile require different levels of review.
- During this session the speakers will review a methodology to conduct hco reviews in particular.
|
 |
Ronny Arijs
Vice President, Global Sustainability and Chief Compliance Officer, Grunenthal; Member, EFPIA Compliance Workgroup; Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium
Presentation Material (Acrobat)
|
 |
Geert Van Gansewinkel
Managing Director, Europe, Polaris, Amsterdam
Presentation Material (Acrobat)
|
|
|
8:45 am
 |
Case Study in Implementing a Global Transparency Solution
David J. Eiben
Director, IS Business Partnering, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
Presentation Material (Acrobat)
|
 |
Tom McCreadie
Sales Engineer, Compliance Solutions, Cegedim, Richmond, VA
Presentation Material (Acrobat)
|
 |
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA (Moderator)
|
|
|
9:15 am
 |
The Status of Implementation of EFPIA's Code by Member Associations and, to the Extent Countries have done so, where are there Consistencies/Inconsistencies among the Codes
D. Jeffrey Campbell, Esq.
Managing Principal, Porzio, Bromberg & Newman; President, CEO, Porzio Life Sciences, LLC and Porzio Governmental Affairs, LLC, Morristown, NJ
Presentation Material (Acrobat)
|
|
|
9:45 am
 |
Best Practices in Implementing a Coordinated Global Transparency Program
Sarah Volden
Manager, Pharmaceutical & Life Science Advisory Services, PwC, Los Angeles, CA
|
 |
Alexis Wong
Alexis Wong, Manager, Pharmaceutical & Life Science Advisory Services, PwC, Denver, CO
Presentation Material (Acrobat)
|
|
|
|
10:15 am |
Break
|
|
|
|
10:30 am |
Practical Approaches to Global Transparency Compliance
- French Sunshine: What have We Learned?
- Global versus Local Considerations
- Navigating Practical Challenges
- Inconsistent Rules
- Tight Timelines
- Data Privacy
- Customer Concerns
- Leveraging the Benefits of Transparency
|
 |
Sujata Dayal, JD, LLM
Vice President Health Care Compliance and Privacy, Pharmaceuticals, Johnson & Johnson, Former, Global Chief Compliance Officer and Corporate Vice President, Biomet, Inc., Former Ethics and Compliance Officer - Pharmaceutical Products, Abbott Laboratories, Chicago, IL
|
|
|
Ashish Kalgaonkar, MBA
Senior Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN
|
 |
Michael D. Petty, Esq.
Partner, King & Spalding LLP; Former Vice President of Development and Regulatory Law, Amgen Inc., Washington, DC
|
 |
Carolyn Bruguera, Esq.
Vice President, Consulting Services and General Counsel, R-Squared; Former Vice President and General Counsel, Hansen Medical, Princeton, NJ (Moderator)
Presentation Material (Acrobat)
|
|
|
|
12:00 pm |
Adjournment
|
Go to Agenda:
Day 1 | Day 2
|
|
